The prognostic role of the epithelial–mesenchymal transition markers E‐cadherin and Slug in laryngeal squamous cell carcinoma. Issue 4 (31st March 2015)

• Record Type: Journal Article
• Authors: Cappellesso, Rocco; Marioni, Gino; Crescenzi, Marika; Giacomelli, Luciano; Guzzardo, Vincenza; Mussato, Alessio; Staffieri, Alberto; Martini, Alessandro; Blandamura, Stella; Fassina, Ambrogio
• Is Part Of: Histopathology. Volume 67:Issue 4(2015)
• Page Start: 491
• Page End: 500
• Publication Date: 2015-03-31
• Subjects: epithelial–mesenchymal transition -- laryngeal carcinoma -- neck lymph node metastasis -- prognosis; Histology, Pathological -- Periodicals; 611.018
• DOI: 10.1111/his.12668
• Languages: English
• ISSNs: 0309-0167

Abstract

Abstract : Aims: Laryngeal squamous cell carcinoma (LSCC) prognosis is definitely related to lymph node metastasis. Epithelial–mesenchymal transition (EMT) allows neoplastic cells to gain the plasticity and motility required for tumour progression and metastasis. The aim of this study was to investigate the role of EMT in the prognosis of LSCC. Methods and results: Immunohistochemical analysis of E‐cadherin, N‐cadherin, Snail, Slug, ZEB1, and ZEB2 was performed in 37 consecutive LSCC cases. Low E‐cadherin levels and high Slug levels correlated with both disease recurrence ( P = 0.02 and P =0.01, respectively) and shorter disease‐free survival (DFS) ( P = 0.04 and P = 0.02, respectively). Relative expression levels of CDH1, SNAI2, miR‐1 and the miR‐200 family were also evaluated. CDH1, miR‐200a and miR‐200c down‐regulation and SNAI2 overexpression were significantly associated with disease recurrence ( P = 0.03, P = 0.02, P = 0.04, and P = 0.04, respectively). Conclusions: EMT increases tumour recurrence risk and shortens DFS in LSCC. E‐cadherin and Slug immunohistochemical analysis could be useful for identifying patients requiring more aggressive treatment after surgery.